This brand name is authorized in France
The drug SOLUDACTONE contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Potassium canrenoate
UNII M671F9NLEA - CANRENOATE POTASSIUM
|
|
|
|
2
Trometamol
UNII 023C2WHX2V - TROMETHAMINE
|
|
Trometamol acts as a proton acceptor and prevents or corrects acidosis by actively binding hydrogen ions (H+). Tromethamine also acts as an osmotic diuretic, increasing urine flow, urinary pH, and excretion of fixed acids, carbon dioxide and electrolytes. It is used for the prevention and correction of metabolic acidosis. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C03DA02 | Potassium canrenoate | C Cardiovascular system → C03 Diuretics → C03D Potassium-sparing agents → C03DA Aldosterone antagonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 67730914, 69637743 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
